lly glp 1 drug Study flags need to monitor frailty risks with GLP-1 drugs for older adults Lilly's new GLP-1 pill is
Description
U., Detraux, J., De Lepeleire, J
H., Brown-Frandsen K., Kristensen P., Mann J
Short-acting ones (exenatide twice daily and lixisenatide) almost disappear from your blood between doses
Outcomes Figure 1 shows the network of comparisons for the outcomes
By acting as dopamine thermostats, they allow people to turn down the volume of their cravings and distractions
